Drug
LM 364 For
LM 364 For: highest development phase Phase 1/2, developed by LaNova Medicines Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- LaNova Medicines Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| LM-364 for injection NCT07847905 | Phase 1/2 | Advanced Solid Tumor Cancer |
Latest
No recent events.
Follow LM 364 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.